Work

Abstract 2836: Rapamycin prolongs overall survival and progression-free survival in a mouse model of lung cancer in never smokers resistant to erlotinib

Year: 2011

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2011-2836

Authors: Shigeru Kawabata, Jose Mercado, M. Christine Hollander, Willie Wilson, Lucia Regales, William Pao, Pasi A. Janne, Kwok-Kin Wong, Phillip A. Dennis

Institutions: National Cancer Institute, Center for Cancer Research, Memorial Sloan Kettering Cancer Center, Vanderbilt University, Dana-Farber Cancer Institute

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2047217949

Cites:

Cited by:

Related to: 10